Early access
Sign in
Taking people in Saudi ArabiaNo phase

Follows people with lupus in Saudi Arabia over time through a prospective registry

Follows adults with systemic lupus erythematosus to learn how the disease appears and progresses.

Key facts

Who runs it
King Saud University
Where
Riyadh, Saudi ArabiaSee the site
Trial code
Registry title
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
Status
Recruiting
People taking part
1,000 people, planned
Started
20 Dec 2020
Expected to end
1 Nov 2050
Type of study
Observational
Record updated
1 September 2021

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with systemic lupus erythematosus (SLE) in Saudi Arabia, to follow them over time.

Age
Adults older than 18 years (the record lists a minimum age of 19 years).
Sex
All sexes can join.
Disease stage
People must meet the classification criteria for SLE (ACR, SLICC or ACR/EULAR). No limit on how long ago they were diagnosed.

Main reasons for not taking part

  • People who do not meet the SLE classification criteria cannot join.

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Adult patients defined as age greater than 18 years old
  • Patients should fulfil one of the following classification criteria for SLE (ACR, SLICC or ACR/EULAR criteria)
  • No restriction on time of diagnosis

Who cannot take part

  • Patients who don't fulfil classification criteria mentioned above

Where in Saudi Arabia

  • King Saud University Medical CityRiyadh, Saudi ArabiaContact: Ibrahim AlmaghlouthTaking people

About the trial

What the trial wants to find out

SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
Plain-language title
Follows people with lupus in Saudi Arabia over time through a prospective registryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
1 September 2021